Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine-protein kinase | 0.0048 | 0.0152 | 0.0152 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0027 | 0.0026 | 0.091 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0043 | 0.0123 | 0.0123 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0065 | 0.0257 | 0.0257 |
Trypanosoma brucei | Aph-1 protein, putative | 0.0658 | 0.3815 | 1 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0043 | 0.0126 | 0.5 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0043 | 0.0123 | 0.0123 |
Echinococcus granulosus | nervana 2 | 0.0043 | 0.0123 | 0.0123 |
Loa Loa (eye worm) | gamma-secretase subunit aph-1 | 0.1689 | 1 | 1 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0048 | 0.0152 | 0.0152 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0043 | 0.0126 | 0.5 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.0043 | 0.0123 | 0.0123 |
Toxoplasma gondii | AGC kinase | 0.0065 | 0.0257 | 0.5 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0065 | 0.0257 | 0.0257 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0048 | 0.0152 | 0.0152 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0043 | 0.0126 | 0.0126 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.0043 | 0.0123 | 0.0123 |
Entamoeba histolytica | protein kinase 2, putative | 0.0043 | 0.0126 | 0.4453 |
Schistosoma mansoni | gamma-secretase subunit aph-1 | 0.1689 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Echinococcus multilocularis | gamma secretase subunit aph 1 | 0.1689 | 1 | 1 |
Echinococcus granulosus | gamma secretase subunit aph 1 | 0.1689 | 1 | 1 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.0658 | 0.3815 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0048 | 0.0152 | 0.5363 |
Echinococcus granulosus | nervana 2 | 0.0043 | 0.0123 | 0.0123 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0069 | 0.0283 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Trypanosoma cruzi | Protein kinase B | 0.0048 | 0.0152 | 0.007 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0043 | 0.0126 | 0.0126 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0069 | 0.0283 | 0.0283 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0048 | 0.0152 | 0.0152 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.0658 | 0.3815 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0043 | 0.0123 | 0.0123 |
Echinococcus multilocularis | nervana 2 | 0.0043 | 0.0123 | 0.0123 |
Trichomonas vaginalis | AGC family protein kinase | 0.0069 | 0.0283 | 1 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0048 | 0.0152 | 0.007 |
Entamoeba histolytica | protein kinase, putative | 0.0065 | 0.0257 | 0.909 |
Giardia lamblia | Kinase, AGC PKA | 0.0043 | 0.0126 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0069 | 0.0283 | 0.0283 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0048 | 0.0152 | 0.5363 |
Entamoeba histolytica | protein kinase, putative | 0.0069 | 0.0283 | 1 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0043 | 0.0126 | 0.0126 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.